# EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Jun 30, 2021

- Company: [EDGEWELL PERSONAL CARE Co](/companies/epc.md) (CIK 1096752)
- Form: 10-Q
- Filed: 2021-08-05
- Accepted by EDGAR: Aug 5, 2021, 12:28 ET
- Period: 2021-06-30
- Accession: 0001096752-21-000028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1096752/000109675221000028/epc-20210630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1096752/000109675221000028/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-04-01 to 2021-06-30 | $573.7m | us-gaap:Revenues |
| Revenue | 9 months, 2020-10-01 to 2021-06-30 | $1.54bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2021-04-01 to 2021-06-30 | $303.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2020-10-01 to 2021-06-30 | $838.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2021-04-01 to 2021-06-30 | $270.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-10-01 to 2021-06-30 | $705.3m | us-gaap:GrossProfit |
| Research and development | 3 months, 2021-04-01 to 2021-06-30 | $14.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2020-10-01 to 2021-06-30 | $42.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2021-04-01 to 2021-06-30 | $97.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-10-01 to 2021-06-30 | $284.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-04-01 to 2021-06-30 | $71.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-10-01 to 2021-06-30 | $175.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-04-01 to 2021-06-30 | $16.4m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-10-01 to 2021-06-30 | $51.1m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-04-01 to 2021-06-30 | $13.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-10-01 to 2021-06-30 | $25.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | $40.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-10-01 to 2021-06-30 | $72.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-04-01 to 2021-06-30 | $0.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-10-01 to 2021-06-30 | $1.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-04-01 to 2021-06-30 | $0.75 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-10-01 to 2021-06-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-04-01 to 2021-06-30 | 55,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-10-01 to 2021-06-30 | 55,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-10-01 to 2021-06-30 | $155.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-10-01 to 2021-06-30 | $34.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months, 2020-10-01 to 2021-06-30 | $16.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2020-10-01 to 2021-06-30 | $9.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2021-06-30 | $1.10bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $3.65bn | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $547.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-06-30 | $2.14bn | us-gaap:Liabilities |
| Long-term debt | at 2021-06-30 | $1.23bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2021-06-30 | $1.51bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 44,830 characters.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 20, 2020 (the “2020 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2020 Annual Report.

#### Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses. Many factors outside our control (including the ongoing COVID-19 pandemic) could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2020 Annual Report.

#### Non-GAAP Financial Measures

While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring costs, acquisition and integration costs, cost of early retirement of long-term debt, the UK tax rate increase, incremental pandemic charges, business evaluation costs, and the gain on the sale of the Infant and Pet Care business. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given certain significant events, including the Project Fuel restructuring and recent acquisitions and divestitures, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our non-GAAP measures:

- We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions, and divestitures. This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
- We utilize “adjusted” non-GAAP measures including gross profit, SG&A, operating income, income taxes, net earnings, and diluted earnings per share internally to make operating decisions. The following items are excluded when analyzing non-GAAP measures: restructuring and related costs, acquisition and integration costs, cost of early retirement of long-term debt, the UK tax rate increase, incremental pandemic charges, the gain on sale of the Infant and Pet Care business, and advisory expenses in connection with the evaluation of the Feminine and Infant Care businesses.

All comparisons are with the same period in the prior year, unless otherwise noted.

#### Industry and Market Data

Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal data and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in Item 1A. Risk Factors in Part I of our 2020 Annual Report. These and other factors could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

#### Trademarks and Trade Names

We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We may also refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

#### Impact of COVID-19

On March 11, 2020, the World Health Organization declared the novel coronavirus 2019 (“COVID-19”) a worldwide pandemic, which has impacted individuals, families, companies and economies around the world. Throughout the pandemic, we have taken and continue to take significant measures to protect our employees and business, while remaining in compliance with local guidelines and requirements.

The Company’s top priority during this time continues to be ensuring the health and welfare of our employees and additional measures have been put in place at all of our manufacturing locations. To date, we have not experienced any material operational disruptions across our manufacturing or distribution facilities.

The prolonged COVID-19 environment has resulted in increased supply chain challenges across product procurement and distribution. The continued duration and severity of COVID-19 may cause further disruptions related to our key suppliers, increase procurement costs and impact our ability to hire and retain employees, which may result in higher labor costs going forward. However, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.

We expect to maintain adequate liquidity during these uncertain times and we will continue to assess the impact that COVID-19 has on our liquidity needs and current economic market conditions. As noted within “Liquidity and Capital Resources” below, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources, including our ability to enter into the unsecured indenture agreement for 4.125% Senior Notes in the amount of $500 due April 1, 2029 (the “2029 Notes”).

### Significant Events

### Acquisitions

On September 2, 2020, the Company completed the acquisition of Cremo, a premier men's grooming company in the U.S, in an all-cash transaction at a purchase price of $233.9. As a result of the acquisition, Cremo became a wholly owned subsidiary of the Company. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for further discussion on the Cremo acquisition.

### Divestiture

On December 17, 2019, we completed the sale of our Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. For further information on the divestiture of the Infant and Pet Care business, refer to Note 2 of Notes to Condensed Consolidated Financial Statements.

### Executive Summary

The following is a summary of key results for the third quarter and first nine months of fiscal 2021 compared to the third quarter and first nine months of fiscal 2020. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring charges, acquisition and integration costs, cost of early retirement of long-term debt, the UK tax rate increase, incremental pandemic charges, the gain on sale of the Infant and Pet Care business, and Feminine and Infant Care evaluation costs, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.

### Third Quarter of Fiscal 2021

- Net sales in the third quarter of fiscal 2021 were $573.7, up 18.6% compared to the prior year quarter. Organic net sales increased 12.5% compared to the prior year quarter, due to increased demand across all segments after reduced demand in the prior year quarter as a result of the COVID-19 pandemic. Net sales increased in both North America and International markets.
- Net earnings in the third quarter of fiscal 2021 were $40.8 compared to $4.7 in the prior year quarter. On an adjusted basis, net earnings for the third quarter of fiscal 2021 increased 37.0% to $49.2. Adjusted earnings increased due to higher net sales and improved margins partially offset by higher advertising and promotional expense (“A&P”) in support of executing our category and brand strategies and new product launches across core geographies and markets.
- Net earnings per diluted share during the third quarter of fiscal 2021 were $0.74 compared to $0.09 in the prior year quarter. On an adjusted basis, net earnings per diluted share during the third quarter of fiscal 2021 was $0.89 compared to $0.66 in the prior year quarter.

|  | Three Months Ended June 30, 2021 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP — Reported** | $270.3 | $97.5 | $71.1 | $53.9 $13.1 | $40.8 | $0.74 |
| Restructuring and related costs | 0.2 | 2.8 | 8.2 | 8.2 2.0 | 6.2 | 0.11 |
| Acquisition and integration costs | — | 1.3 | 1.3 | 1.3 0.3 | 1.0 | 0.02 |
| UK tax rate increase | — | — | — | — (1.2) | 1.2 | 0.02 |
| **Total Adjusted Non-GAAP** | $270.5 | $93.4 | $80.6 | $63.4 $14.2 | $49.2 | $0.89 |
| GAAP as a percent of net sales | 47.1% | 17.0% | 12.4% | GAAP effective tax rate | 24.2% |  |
| Adjusted as a percent of net sales | 47.2% | 16.3% | 14.0% | Adjusted effective tax rate | 22.4% |  |

|  | Three Months Ended June 30, 2020 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP — Reported** | $222.7 | $91.3 | $43.5 | $5.3 $0.6 | $4.7 | $0.09 |
| Restructuring and related costs | 0.1 | 2.3 | 10.4 | 10.4 2.3 | 8.1 | 0.15 |
| Acquisition and integration costs | — | 0.3 | 0.3 | 0.3 — | 0.3 | 0.01 |
| Cost of early retirement of long-term debt | — | — | — | 26.2 6.4 | 19.8 | 0.36 |
| COVID-19 expenses | 3.9 | — | 3.9 | 3.9 0.9 | 3.0 | 0.05 |
| **Total Adjusted Non-GAAP** | $226.7 | $88.7 | $58.1 | $46.1 $10.2 | $35.9 | $0.66 |
| GAAP as a percent of net sales | 46.0% | 18.9% | 9.0% | GAAP effective tax rate | 11.3% |  |
| Adjusted as a percent of net sales | 46.8% | 18.3% | 12.0% | Adjusted effective tax rate | 22.1% |  |

### First Nine Months of Fiscal 2021

- Net sales for the first nine months of fiscal 2021 increased 5.7% to $1,544.1. Organic net sales increased 2.1% compared to the prior year period, due to increases in Wet Shave globally and Sun and Skin Care in North America

offset by declines in Feminine Care in North America. The growth in net sales for Wet Shave and Sun and Skin Care reflects improved underlying category performance, particularly in the United States, as well as increased brand and promotional investments. The decline in Feminine Care was primarily related to lower category demand related to the prior year’s pantry loading due to COVID-19.

- Net earnings for the first nine months of fiscal 2021 were $72.9 compared to $46.6 in the prior year. On an adjusted basis, net earnings for the first nine months of fiscal 2021 decreased 4.5% to $111.0. Adjusted earnings decreased due to higher A&P across Wet Shave products, including Men’s and Women’s systems, and Feminine Care products. The increase in A&P was partially offset by higher net sales and improved gross margins.
- Net earnings per diluted share during the first nine months of fiscal 2021 were $1.32 compared to $0.86 in the prior year period. On an adjusted basis, as illustrated in the following table, net earnings per diluted share during the first nine months of fiscal 2021 were $2.01 compared to $2.13 in the prior year quarter.

|  | Nine Months Ended June 30, 2021 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP — Reported** | $705.3 | $284.0 | $175.6 | $98.6 $25.7 | $72.9 | $1.32 |
| Restructuring and related costs | 0.3 | 6.2 | 18.1 | 18.1 4.4 | 13.7 | 0.25 |
| Acquisition and integration costs | 1.3 | 3.3 | 4.6 | 4.6 1.1 | 3.5 | 0.06 |
| Cost of early retirement of long-term debt | — | — | — | 26.1 6.4 | 19.7 | 0.36 |
| UK tax rate increase | — | — | — | — (1.2) | 1.2 | 0.02 |
| **Total Adjusted Non-GAAP** | $706.9 | $274.5 | $198.3 | $147.4 $36.4 | $111.0 | $2.01 |
| GAAP as a percent of net sales | 45.7% | 18.4% | 11.4% | GAAP effective tax rate | 26.1% |  |
| Adjusted as a percent of net sales | 45.8% | 17.8% | 12.8% | Adjusted effective tax rate | 24.8% |  |

|  | Nine Months Ended June 30, 2020 Gross Profit | SG&A | Operating Income | EBIT Income taxes | Net Earnings | Diluted EPS |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **GAAP — Reported** | $658.8 | $307.8 | $134.7 | $63.1 $16.5 | $46.6 | $0.86 |
| Restructuring and related costs | 0.2 | 10.0 | 30.8 | 30.8 6.9 | 23.9 | 0.44 |
| Acquisition and integration costs | — | 32.0 | 32.0 | 32.0 7.8 | 24.2 | 0.45 |
| Cost of early retirement of long-term debt | — | — | — | 26.2 6.4 | 19.8 | 0.36 |
| Gain on sale of Infant and Pet Care business | — | — | — | (4.1) (2.6) | (1.5) | (0.03) |
| COVID-19 expenses | 3.9 | — | 3.9 | 3.9 0.9 | 3.0 | 0.05 |
| Feminine and Infant Care evaluation costs | — | 0.3 | 0.3 | 0.3 0.1 | 0.2 | — |
| **Total Adjusted Non-GAAP** | $662.9 | $265.5 | $201.7 | $152.2 $36.0 | $116.2 | $2.13 |
| GAAP as a percent of net sales | 45.1% | 21.1% | 9.2% | GAAP effective tax rate | 26.1% |  |
| Adjusted as a percent of net sales | 45.4% | 18.2% | 13.8% | Adjusted effective tax rate | 23.7% |  |

### Operating Results

The following table presents changes in net sales for the third quarter and first nine months of fiscal 2021, as compared to the corresponding period in fiscal 2020, and provides a reconciliation of organic net sales to reported amounts.

### Net Sales

| Net Sales - Total Company Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $483.9 |  | $1,460.9 |  |
| Organic | 60.5 | 12.5% | 31.0 | 2.1% |
| Impact of Cremo acquisition | 13.7 | 2.8% | 44.9 | 3.1% |
| Impact of the sale of the Infant and Pet Care business | — | —% | (26.8) | (1.8)% |
| Impact of currency | 15.6 | 3.3% | 34.1 | 2.3% |
| Net sales - current year | $573.7 | 18.6% | $1,544.1 | 5.7% |

For the third quarter of fiscal 2021, net sales were $573.7, an 18.6% increase compared to the prior year quarter. Organic net sales increased 12.5% driven by strong Sun Care and Wet Shave performance across both North America and International markets, and in part reflecting the impact of cycling prior year COVID-19 related headwinds.

For the first nine months of fiscal 2021, net sales were $1,544.1, a 5.7% increase compared to the prior year period. Organic net sales increased 2.1% compared to the prior year period. Organic net sales increases were driven by higher volumes of Wet Shave and Sun Care, particularly in North America, reflective of higher demand due to cycling COVID-19 headwinds in the prior year period and favorable pricing impacting Sun and Skin Care. Lower volumes for Feminine Care were driven by COVID-19 demand declines and pantry loading during the prior year period.

For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”

### Gross Profit

Gross profit was $270.3 during the third quarter of fiscal 2021, compared to $222.7 in the prior year quarter. Gross margin as a percent of net sales for the third quarter of fiscal 2021 was 47.1%. Adjusted gross margin percentage was 47.2%, an increase of 40-basis points compared to the prior year quarter, as favorable pricing, product mix and trade promotional spending, and gross savings from Project Fuel more than offset higher commodity, labor and distribution costs.

Gross profit was $705.3 during the first nine months of fiscal 2021, compared to $658.8 in the prior year period. Gross margin as a percent of net sales for the first nine months of fiscal 2021 was 45.7%, up 60-basis points compared to the prior year period. Adjusted gross margin percentage was 45.8%, up 40-basis points from the prior year period, driven by favorable price and category mix, gross savings from Project Fuel and favorable foreign currency fluctuations offset by rising commodity and supply chain costs and higher obsolescence charges.

### Selling, General and Administrative Expense

Selling, general and administrative expense (“SG&A”) was $97.5 in the third quarter of fiscal 2021, or 17.0% of net sales, compared to $91.3 in the prior year quarter, or 18.9% of net sales. Adjusted SG&A as a percent of net sales was 16.3%, a decline of 200-basis points as the benefit of sales leverage in the current quarter more than offset increased operating costs associated with the Cremo business and negative foreign currency exchange.

SG&A was $284.0 in the first nine months of fiscal 2021, or 18.4% of net sales, as compared to $307.8 in the prior year period, or 21.1% of net sales. Adjusted SG&A as a percent of net sales was 17.8%, a decrease of 40-basis points, as stronger cost control and the benefit of sales leverage more than offset investments made in increased talent and capabilities and unfavorable foreign currency fluctuations.

### Advertising and Sales Promotion Expense

For the third quarter of fiscal 2021, A&P was $81.9, up $14.4 compared to the prior year quarter of $67.5. A&P as a percent of net sales was 14.3%, up from 13.9% in the prior year period. For the first nine months of fiscal 2021, A&P was $191.5, up $35.9 compared to the prior year period. A&P as a percent of net sales was 12.4%, as compared to 10.7% in the prior year period. The increase in A&P was the result of investments in and focus on critical commercial efforts supporting the Schick Hydro relaunch, Schick Stubble Eraser® product launch, Skintimate campaign, and Men’s systems development in Japan, increased support for the Sun Care business and the inclusion of Cremo brand investments.

### Research and Development Expense

Research and development expense (“R&D”) for the third quarter of fiscal 2021 was $14.6, compared to $12.4 in the prior year quarter. As a percent of net sales, R&D was 2.5% in the third quarter of fiscal 2021 compared to 2.6% in the prior year quarter.

R&D for the first nine months of fiscal 2021 was $42.6, compared to $40.1 in the prior year period. As a percent of net sales, R&D was 2.8% in the first nine months of fiscal 2021, compared to 2.7% in the prior year period. R&D expense was slightly up compared to the prior year driven by incremental investments in resources and capabilities in support of the Company’s focus on innovation and development primarily in the Sun and Skin Care segment.

### Interest Expense Associated with Debt

Interest expense associated with debt for the third quarter of fiscal 2021 was $16.4, compared to $15.5 in the prior year quarter. For the first nine months of fiscal 2021, interest expense was $51.1, compared to $43.7 in the prior year period. The increase in interest expense was the result of higher average outstanding debt and higher interest rate primarily as a result of the issuance of the 5.5% $750 Senior Notes due 2028 issued in May 2020 (the “2028 Notes”).

### Other Expense (Income), Net

Other expense, net was $0.8 in the third quarter of fiscal 2021, compared to income of $3.5 in the prior year quarter. The unfavorable movement in other expenses compared to the prior year quarter was driven by prior year income from hedge settlements. Other income, net was $0.2 during the first nine months of fiscal 2021, compared to expense of $5.8 during the first nine months of fiscal 2020. The favorable movement was largely related to unfavorable foreign currency movements in the prior period.

### Income Tax Provision

The effective tax rate for the first nine months of fiscal 2021 was 26.1%, compared to 26.1% in the prior year period. On an adjusted basis, the effective tax rate was 24.8% and 23.7% for the first nine months of fiscal 2021 and fiscal 2020, respectively. The fiscal 2021 effective tax rate and adjusted effective tax rate reflects higher unfavorable global intangible low-tax income and Internal Revenue Service Code Section 162(m) permanent adjustments compared to fiscal 2020.

The following table presents a reconciliation of the adjusted effective tax rate, which is a non-GAAP measure:

|  | Nine Months Ended June 30, 2021 Reported | Adjustments (1) | Adjusted (Non-GAAP) | Nine Months Ended June 30, 2020 Reported | Adjustments (1) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Earnings before income taxes | $98.6 | $48.8 | $147.4 | $63.1 | $89.1 | $152.2 |
| Income tax provision | 25.7 | 10.7 | 36.4 | 16.5 | 19.5 | 36.0 |
| Net earnings | $72.9 | $38.1 | $111.0 | $46.6 | $69.6 | $116.2 |
| Effective tax rate | 26.1% |  |  | 26.1% |  |  |
| Adjusted effective tax rate |  |  | 24.8% |  |  | 23.7% |

(1) Includes adjustments for expenses management excludes when analyzing the operating performance of the Company. Refer to the GAAP to Non-GAAP reconciliation above for a detailed listing of adjustments.

### Project Fuel

Project Fuel is an enterprise-wide transformational initiative that was launched in the second fiscal quarter of 2018, to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes. Project Fuel is facilitating further re-investment in our growth strategy while enabling us to achieve its desired future state operations.

Fiscal third quarter 2021 Project Fuel related gross savings were approximately $19, bringing cumulative gross savings to approximately $264. We now expect Project Fuel to generate approximately $280 in total project gross savings by the end of the 2021 fiscal year. The savings generated will be used to fuel investments and brand building in strategic growth initiatives, mitigate anticipated operational cost headwinds from inflation and other rising input costs and improve our overall profitability and cash flows.

To implement the restructuring element of Project Fuel, we now expect to incur one-time pre-tax charges of approximately $160 through the end of the 2021 fiscal year.

Restructuring and related charges were $8.2 and $18.1 for the third quarter and nine months ended June 30, 2021, respectively, bringing cumulative charges to $151.7 for the project.

Capital expenditures for Project Fuel were $8.4 for the nine months ended June 30, 2021 bringing cumulative capital expenditures to $66.5 for the project.

For further information on our restructuring projects, refer to Note 3 of Notes to Condensed Consolidated Financial Statements.

### Segment Results

The following tables present changes in segment net sales and segment profit for the third quarter and first nine months of fiscal 2021, compared to the corresponding period in fiscal 2020, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 15 of Notes to Condensed Consolidated Financial Statements.

Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis in which shared business functions are allocated between the segments.

### Wet Shave

| Net Sales - Wet Shave Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $278.0 |  | $835.5 |  |
| Organic | 15.9 | 5.7% | 14.8 | 1.8% |
| Impact of currency | 11.0 | 4.0% | 26.4 | 3.1% |
| Net sales - current year | $304.9 | 9.7% | $876.7 | 4.9% |

Wet Shave net sales for the third quarter of fiscal 2021 increased 9.7% compared to the prior year quarter, inclusive of a 4.0% increase due to currency movements. Organic net sales increased $15.9, or 5.7%, driven by on-going growth in Women’s shave, both branded and private label, and higher consumption across the full category. By region, North America organic net sales increased 4.6%, while International markets increased 6.6%.

Wet Shave net sales for the first nine months of fiscal 2021 increased 4.9%, inclusive of a 3.1% increase due to currency movements. Organic net sales increased $14.8, or 1.8%. The increase in organic net sales was driven by growth in Women’s systems, partially offset by declines in Men’s systems and Shave Preps. Women’s systems growth included increases in Intuition, Skintimate and Hydro Silk, while Men’s systems saw growth in Hydro and Bulldog, offsetting declines in other brands. By region, North America organic net sales increased 2.0% while International markets increased 1.6%.

| Segment Profit - Wet Shave Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $44.6 |  | $142.0 |  |
| Organic | (4.1) | (9.2)% | (6.4) | (4.5)% |
| Impact of currency | 2.6 | 5.8% | 6.0 | 4.2% |
| Segment profit - current year | $43.1 | (3.4)% | $141.6 | (0.3)% |

Wet Shave segment profit for the third quarter of fiscal 2021 was $43.1, down $1.5, or 3.4%, compared to the prior year quarter, inclusive of the impact of currency movements. Organic segment profit decreased $4.1, or 9.2%, as increased net sales and favorable gross margins were more than offset by higher A&P for Men’s systems during the quarter.

Wet Shave segment profit for the first nine months of fiscal 2021 was $141.6, down $0.4, or 0.3%, from the prior year period, inclusive of the impact of currency movements. Organic segment profit decreased $6.4, or 4.5%, primarily due to significantly higher A&P in support of Men’s and Women’s systems, offset partially by higher gross margins and lower overheads.

### Sun and Skin Care

Sun and Skin Care segment net sales and profit are affected by the seasonality of sun care products. As a result, segment net sales and profit have historically been higher in the second and third quarters of the fiscal year.

| Net Sales - Sun and Skin Care Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $136.9 |  | $369.5 |  |
| Organic | 40.4 | 29.5% | 36.2 | 9.8% |
| Impact of Cremo acquisition | 13.7 | 10.0% | 44.9 | 12.2% |
| Impact of currency | 4.2 | 3.1% | 7.1 | 1.9% |
| Net sales - current year | $195.2 | 42.6% | $457.7 | 23.9% |

Sun and Skin Care net sales for the third quarter of fiscal 2021 increased 42.6% compared to the prior year quarter, inclusive of a 10.0% increase due to the Cremo acquisition and a 3.1% increase due to currency movements. Organic net sales increased $40.4, or 29.5%. The increase in organic net sales was primarily driven by Sun Care growth of nearly 50%, reflecting a sharp recovery in consumption after COVID-19 impacted declines in the prior year period, as well as 17% organic net sales growth in Men’s grooming. Wet Ones organic net sales contracted $8.5, or 32% in the quarter, reflecting ongoing high retailer inventory and lower consumption as we cycled prior year COVID-19 driven performance.

Sun and Skin Care net sales for the first nine months of fiscal 2021 increased 23.9% compared to the prior year period, inclusive of a 12.2% increase due to the Cremo acquisition and a 1.9% increase due to currency movements. Organic net sales increased $36.2, or 9.8%. The organic net sales increase was driven by Sun Care growth which totaled 10% globally reflecting a sharp recovery in consumption after COVID-19, and favorable pricing in International markets. Wet Ones grew 9% driven by higher volumes in the first half of fiscal 2021. Men’s Grooming increased over 12% driven by Jack Black and Bulldog.

| Segment Profit - Sun and Skin Care Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $23.5 |  | $67.9 |  |
| Organic | 18.4 | 78.3% | 11.5 | 16.9% |
| Impact of Cremo acquisition | 1.9 | 8.1% | 5.7 | 8.4% |
| Impact of currency | 1.2 | 5.1% | 1.3 | 1.9% |
| Segment profit - current year | $45.0 | 91.5% | $86.4 | 27.2% |

Segment profit for the third quarter of fiscal 2021 was $45.0, an increase of $21.5, compared to the prior year quarter. Organic segment profit, excluding the Cremo acquisition and currency movements, increased $18.4, driven by increased net sales and gross margin from favorable volumes and pricing, offset by unfavorable materials costs.

Segment profit for the first nine months of fiscal 2021 was $86.4, an increase of $18.5, or 27.2%, compared to the prior year period. Organic segment profit, excluding the Cremo acquisition and currency movements, increased $11.5, or 16.9%, driven by increased net sales and gross margin from favorable volumes and pricing, offset by unfavorable materials costs.

### Feminine Care

| Net Sales - Feminine Care Period Ended June 30, 2021 | Q3 | % Chg | Nine Months | % Chg |
| --- | ---: | ---: | ---: | ---: |
| Net sales - prior year | $69.0 |  | $229.1 |  |
| Organic | 4.2 | 6.1% | (20.0) | (8.7)% |
| Impact of currency | 0.4 | 0.6% | 0.6 | 0.2% |
| Net sales - current year | $73.6 | 6.7% | $209.7 | (8.5)% |

Feminine Care net sales for the third quarter of fiscal 2021 increased $4.6, or 6.7%. The increase in net sales was largely driven by increased consumption as the category recovered from the prior year’s steep declines due to COVID-19.

Feminine Care net sales for the first nine months of fiscal 2021 decreased $19.4, or 8.5%. Net sales declines were driven by overall category declines, the effect of the prior year pantry loading and the negative effect of distribution losses.

| Segment Profit - Feminine Care Period Ended June 30, 2021 | Q3 | %Chg | Nine Months | %Chg |
| --- | ---: | ---: | ---: | ---: |
| Segment profit - prior year | $12.0 |  | $43.4 |  |
| Organic | 1.4 | 11.7% | (15.8) | (36.4)% |
| Impact of currency | 0.3 | 2.5% | 0.5 | 1.1% |
| Segment profit - current year | $13.7 | 14.2% | $28.1 | (35.3)% |

Feminine Care segment profit for the third quarter of fiscal 2021 was $13.7, an increase of $1.7, or 14.2%, compared to the prior year quarter. The decline was driven by higher gross margin, reflecting increased volumes, favorable trade offset by higher costs, including materials cost and warehousing and distribution charges, and higher A&P.

Feminine Care segment profit for the first nine months of fiscal 2021 was $28.1, a decrease of $15.3, or 35.3%, from the prior year period, primarily due to unfavorable gross margin from lower sales volumes across all products, unfavorable cost mix due to higher materials and warehouse and distribution costs, and higher A&P.

### All Other

The Infant and Pet Care business divestiture, completed in December 2019, disposed of the entirety of the operations of the All Other segment. The results below represent the impact of the divestiture to segment performance:

| Net Sales - All Other Period Ended June 30, 2021 | Nine Months | %Chg |
| --- | ---: | ---: |
| Net sales - prior year | $26.8 |  |
| Organic | — | —% |
| Impact of the sale of the Infant and Pet Care business | (26.8) | (100.0)% |
| Impact of currency | — | —% |
| Net sales - current year | $— | (100.0)% |

31

| Segment Profit - All Other Period Ended June 30, 2021 | Nine Months | %Chg |
| --- | ---: | ---: |
| Segment profit - prior year | $3.1 |  |
| Organic | — | —% |
| Impact of the sale of the Infant and Pet Care business | (3.1) | (100.0)% |
| Impact of currency | — | —% |
| Segment profit - current year | $— | (100.0)% |

### General Corporate and Other Expenses

|  | Quarter Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Corporate expenses | $15.7 | $17.7 | $41.2 | $41.9 |
| Restructuring and related costs | 8.2 | 10.4 | 18.1 | 30.8 |
| Acquisition and integration costs | 1.3 | 0.3 | 4.6 | 32.0 |
| Cost of early retirement of long-term debt | — | 26.2 | 26.1 | 26.2 |
| Gain on sale of Infant and Pet Care business | — | — | — | (4.1) |
| COVID-19 expenses | — | 3.9 | — | 3.9 |
| Feminine and Infant Care evaluation costs | — | — | — | 0.3 |
| General corporate and other expenses | $25.2 | $58.5 | $90.0 | $131.0 |
| % of net sales | 4.4% | 12.1% | 5.8% | 9.0% |

For the third quarter of fiscal 2021, general corporate expenses were $15.7, or 2.7% of net sales, compared to $17.7, or 3.7% of net sales, in the prior year quarter. For the third quarter of fiscal 2021, the decline in corporate expense was primarily due to lower compensation expenses, Project Fuel savings and lower discretionary spending.

For the first nine months of fiscal 2021, general corporate expenses were $41.2, or 2.7% of net sales, compared to $41.9, or 2.9% of net sales, in the prior year period. For the nine months ended June 30, 2021, the slight decline in corporate expense was primarily due to Project Fuel savings and lower discretionary spending.

### Liquidity and Capital Resources

To date, COVID-19 has not had a significant impact on our liquidity or capital resources. However, the ongoing COVID-19 pandemic has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.

At June 30, 2021, a portion of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

The counterparties that hold our deposits consist of major financial institutions. We consistently monitor positions with, and the credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,274.8 at June 30, 2021, including $24.8 tied to variable interest rates. Our total borrowings at September 30, 2020 were $1,271.1. We had outstanding international borrowings, recorded in Notes payable, of $24.8 and $21.1 as of June 30, 2021 and September 30, 2020, respectively.

As previously discussed, on March 8, 2021, the Company entered into the 2029 Notes. The Company used the net proceeds of the 2029 Notes, together with cash on hand, to satisfy and discharge the obligations outstanding under its 4.70% Senior Notes in the amount of $500 due 2022 (the “2022 Notes”).

Historically, we have generated, and expect to continue to generate, positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact COVID-19 will have on our cash flows, we believe our cash on hand, cash flows from operations and borrowing capacity under our U.S Revolving Credit Facility due 2025 (the “Revolving Credit Facility”) will be sufficient to satisfy our future working capital requirements, interest payments, R&D activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.

Short-term financing needs consist primarily of working capital requirements and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity on terms that are favorable to us.

The expected minimum required contribution to our pension plans in fiscal 2021 is $6.3; however, discretionary contributions may also be made. During the first nine months of fiscal 2021 we contributed $4.3 to our pension plans.

As of June 30, 2021, we were in compliance with the provisions and covenants associated with our debt agreements.

### Cash Flows

A summary of our cash flow activities is provided in the following table:

| Net cash from (used by): | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: |
| Operating activities | $155.9 | $118.6 |
| Investing activities | (26.1) | 71.3 |
| Financing activities | (59.9) | (21.6) |
| Effect of exchange rate changes on cash | 2.9 | 2.0 |
| Net increase in cash and cash equivalents | $72.8 | $170.3 |

#### Operating Activities

Cash flow from operating activities was $155.9 during the first nine months of fiscal 2021, compared to cash flows from operating activities of $118.6 during the same period in the prior year. The increase in cash from operations was primarily related to increased net earnings.

#### Investing Activities

Cash flow used by investing activities was $26.1 during the first nine months of fiscal 2021, compared to cash inflows of $71.3 during the same period in the prior year. During the nine months ended June 30, 2021, we collected $7.5 of proceeds from the sale of the Infant and Pet Care business, compared to $95.8 in the prior year quarter. Capital expenditures were $34.1 during the first nine months of fiscal 2021 compared to $26.9 during the same period in the prior year. Additionally, other investing cash inflows related to the collection of receivables from our $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”) totaled $2.6 and $3.9 during the first nine months of fiscal 2021 and 2020, respectively, as a result of collections on the deferred purchase price of accounts receivables sold.

#### Financing Activities

Net cash used by financing activities was $59.9 during the first nine months of fiscal 2021, compared to $21.6 during the same period in the prior year. During the first nine months of fiscal 2021, we repurchased $9.2 of our common stock under our 2018 Board authorization to repurchase our common stock (the “Repurchase Plan”). The Company replaced its 2022 Notes with the issuance of 2029 Notes, together with cash on hand. Additional financing cash outflows incurred were related to costs of early debt retirement of the 2022 Notes totaling $26.1 and debt issuance costs of $6.5. Dividend payments totaled $16.7 in the first nine months of fiscal 2021. Additionally, cash flows associated with the Accounts Receivable Facility were inflows of $0.8 during the first nine months of fiscal 2021 compared to financing outflows of $14.4 in the prior year period. In the prior year period, the Company replaced its 4.7% Senior Notes in the amount of $600 Senior Notes due 2021 with the $750 2028 Senior Notes. Early debt retirement of the 2021 Senior Notes totaling $26.2 and debt issuance costs totaling $10.4. The Company had net repayments of its Revolving Credit Facility during the nine months ended June 30, 2020 totaling $117.0.

### Share Repurchases

During the first nine months of fiscal 2021, we repurchased 0.3 shares of our common stock for $9.2. We have 9.7 shares remaining under the Repurchase Plan. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.

### Dividends

On May 6, 2021, the Company’s Board of Directors (the “Board”) declared a cash dividend of $0.15 per share of common stock outstanding. The dividend was paid on July 7, 2021 to holders of record as of the close of business on June 4, 2021. Dividends declared during the nine months ended June 30, 2021 totaled $25.4. Payments made for dividends during the nine months ended June 30, 2021 totaled $16.7.

On August 5, 2021, the Board declared a quarterly cash dividend of $0.15 per common stock outstanding for the third fiscal quarter. The dividend is payable October 5, 2021 to stockholders of record as of the close of business on September 9, 2021.

### Commitments and Contingencies

#### Contractual Obligations

During the first nine months of fiscal 2021, there were no net repayments on the Revolving Credit Facility. As of June 30, 2021, future minimum repayments of debt were: $750.0 in fiscal 2028 and $500.0 in fiscal 2029.

There have been no other material changes in our contractual obligations since the presentation in our 2020 Annual Report.

## Market risk

As filed, 1,194 characters.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 14 of Notes to Condensed Consolidated Financial Statements. As of June 30, 2021, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of June 30, 2021, our outstanding variable-rate debt included $24.8 related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would not increase materially.

There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2020 Annual Report on Form 10-K.

## Controls and procedures

As filed, 1,143 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2021. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2021 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

Filed Aug 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001096752-21-000028. Last ingested by Listed: Nov 14, 2026, 23:53 ET. No prices; not investment advice.
